Daiichi Sankyo
Jeffrey Stein is a finance professional currently serving as the Manager of Asset & Portfolio Management Finance at Daiichi Sankyo, Inc. since November 2022. Prior experience includes roles as a Senior Financial Analyst in BP&A at NJM Insurance Group from October 2021 to November 2022, and various positions at Church & Dwight Co., Inc. from May 2019 to October 2021, including Sales Finance Analyst III and Sales Finance Analyst II. Jeffrey also worked as a Financial Analyst at Bausch Health Companies Inc. from April 2018 to March 2019, and previously at Church & Dwight Co., Inc. from September 2016 to March 2018. Jeffrey holds a Bachelor of Science degree in Finance from Rowan University, completed between 2012 and 2016.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.